Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy

Conditions:   HER2-positive Breast Cancer;   Chemotherapy Effect;   Circulating Tumor DNA Intervention:   Diagnostic Test: LiquidSCAN(Trade Mark) / CancerSCAN(Trade Mark) Sponsor:   Samsung Medical Center Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials